vs
Side-by-side financial comparison of Sensus Healthcare, Inc. (SRTS) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $4.9M, roughly 1.4× Sensus Healthcare, Inc.). TECHPRECISION CORP runs the higher net margin — -20.8% vs -64.1%, a 43.4% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -62.2%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-2.4M). Over the past eight quarters, TECHPRECISION CORP's revenue compounded faster (-9.2% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
SRTS vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $4.9M | $7.1M |
| Net Profit | $-3.2M | $-1.5M |
| Gross Margin | 38.4% | 5.4% |
| Operating Margin | -63.8% | -19.1% |
| Net Margin | -64.1% | -20.8% |
| Revenue YoY | -62.2% | -6.9% |
| Net Profit YoY | -304.9% | -84.4% |
| EPS (diluted) | $-0.19 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9M | $7.1M | ||
| Q3 25 | $6.9M | $9.1M | ||
| Q2 25 | $7.3M | $7.4M | ||
| Q1 25 | $8.3M | $9.5M | ||
| Q4 24 | $13.1M | $7.6M | ||
| Q3 24 | $8.8M | $8.9M | ||
| Q2 24 | $9.2M | $8.0M | ||
| Q1 24 | $10.7M | $8.6M |
| Q4 25 | $-3.2M | $-1.5M | ||
| Q3 25 | $-943.0K | $825.0K | ||
| Q2 25 | $-1.0M | $-597.0K | ||
| Q1 25 | $-2.6M | $112.0K | ||
| Q4 24 | $1.5M | $-799.0K | ||
| Q3 24 | $1.2M | $-601.0K | ||
| Q2 24 | $1.6M | $-1.5M | ||
| Q1 24 | $2.3M | $-5.1M |
| Q4 25 | 38.4% | 5.4% | ||
| Q3 25 | 39.4% | 27.1% | ||
| Q2 25 | 39.7% | 14.0% | ||
| Q1 25 | 52.2% | 22.0% | ||
| Q4 24 | 54.4% | 13.0% | ||
| Q3 24 | 59.3% | 11.3% | ||
| Q2 24 | 58.7% | 3.0% | ||
| Q1 24 | 62.5% | 14.3% |
| Q4 25 | -63.8% | -19.1% | ||
| Q3 25 | -37.3% | 10.4% | ||
| Q2 25 | -26.6% | -6.3% | ||
| Q1 25 | -31.7% | 3.9% | ||
| Q4 24 | 13.2% | -9.1% | ||
| Q3 24 | 16.9% | -5.5% | ||
| Q2 24 | 21.5% | -16.8% | ||
| Q1 24 | 27.1% | -28.6% |
| Q4 25 | -64.1% | -20.8% | ||
| Q3 25 | -13.7% | 9.1% | ||
| Q2 25 | -14.2% | -8.1% | ||
| Q1 25 | -30.8% | 1.2% | ||
| Q4 24 | 11.8% | -10.5% | ||
| Q3 24 | 13.7% | -6.7% | ||
| Q2 24 | 17.4% | -18.3% | ||
| Q1 24 | 21.3% | -59.5% |
| Q4 25 | $-0.19 | $-0.15 | ||
| Q3 25 | $-0.06 | $0.08 | ||
| Q2 25 | $-0.06 | $-0.06 | ||
| Q1 25 | $-0.16 | $0.01 | ||
| Q4 24 | $0.10 | $-0.08 | ||
| Q3 24 | $0.07 | $-0.06 | ||
| Q2 24 | $0.10 | $-0.16 | ||
| Q1 24 | $0.14 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.1M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $8.0M |
| Total Assets | $53.0M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.1M | $50.0K | ||
| Q3 25 | $24.5M | $220.0K | ||
| Q2 25 | $22.2M | $143.0K | ||
| Q1 25 | $19.1M | $195.0K | ||
| Q4 24 | $22.1M | $165.0K | ||
| Q3 24 | $22.6M | $132.0K | ||
| Q2 24 | $19.0M | $44.8K | ||
| Q1 24 | $14.7M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $48.1M | $8.0M | ||
| Q3 25 | $51.2M | $9.1M | ||
| Q2 25 | $52.1M | $8.2M | ||
| Q1 25 | $53.0M | $8.7M | ||
| Q4 24 | $55.8M | $8.1M | ||
| Q3 24 | $54.1M | $8.9M | ||
| Q2 24 | $52.9M | $7.9M | ||
| Q1 24 | $51.2M | $7.8M |
| Q4 25 | $53.0M | $32.8M | ||
| Q3 25 | $58.3M | $33.8M | ||
| Q2 25 | $58.9M | $32.1M | ||
| Q1 25 | $60.2M | $33.5M | ||
| Q4 24 | $62.2M | $32.2M | ||
| Q3 24 | $59.9M | $35.0M | ||
| Q2 24 | $58.2M | $35.7M | ||
| Q1 24 | $57.3M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $183.0K |
| Free Cash FlowOCF − Capex | $-2.4M | $-827.0K |
| FCF MarginFCF / Revenue | -47.9% | -11.7% |
| Capex IntensityCapex / Revenue | 3.2% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $332.0K | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.2M | $183.0K | ||
| Q3 25 | $2.3M | $-1.1M | ||
| Q2 25 | $3.1M | $646.0K | ||
| Q1 25 | $-2.7M | $396.0K | ||
| Q4 24 | $-827.0K | $-570.0K | ||
| Q3 24 | $4.0M | $-532.0K | ||
| Q2 24 | $4.2M | $107.0K | ||
| Q1 24 | $-8.2M | $-452.0K |
| Q4 25 | $-2.4M | $-827.0K | ||
| Q3 25 | $2.3M | $-2.1M | ||
| Q2 25 | $3.1M | $-604.0K | ||
| Q1 25 | $-2.7M | $-930.0K | ||
| Q4 24 | $-1.1M | $-1.7M | ||
| Q3 24 | $3.6M | $-2.0M | ||
| Q2 24 | $4.2M | $-94.0K | ||
| Q1 24 | $-8.4M | $-900.0K |
| Q4 25 | -47.9% | -11.7% | ||
| Q3 25 | 33.3% | -22.9% | ||
| Q2 25 | 42.2% | -8.2% | ||
| Q1 25 | -32.2% | -9.8% | ||
| Q4 24 | -8.6% | -22.9% | ||
| Q3 24 | 40.9% | -21.8% | ||
| Q2 24 | 45.8% | -1.2% | ||
| Q1 24 | -79.0% | -10.5% |
| Q4 25 | 3.2% | 14.2% | ||
| Q3 25 | 0.1% | 11.0% | ||
| Q2 25 | 0.4% | 16.9% | ||
| Q1 25 | 0.1% | 14.0% | ||
| Q4 24 | 2.3% | 15.4% | ||
| Q3 24 | 3.8% | 15.9% | ||
| Q2 24 | 0.0% | 2.5% | ||
| Q1 24 | 2.2% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | -0.53× | — | ||
| Q3 24 | 3.25× | — | ||
| Q2 24 | 2.62× | — | ||
| Q1 24 | -3.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
